Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded a government funding lapse notice banner. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check49 days agoChange DetectedThe changes add a glossary display toggle and update page metadata by introducing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no visible content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.